A comparison of laser-assisted drug delivery at two output energies for enhancing the delivery of topically applied LMX-4 cream prior to venipuncture

Anesth Analg. 2007 Apr;104(4):847-9. doi: 10.1213/01.ane.0000257925.36641.9e.

Abstract

Background: Laser-assisted drug delivery (LAD) has the potential for facilitating topical anesthesia with reduced onset time.

Methods: In this randomized, double-blind, crossover study we compared the efficacy and adverse event profile of LAD for topical anesthesia before venipuncture using two output energies (2.0 and 3.5 J/cm2).

Results: Mean Visual Analog Scale pain scores were not statistically different (P = 0.57) between the low-energy (mean = 6.7) and high-energy (mean = 8.1) lasers.

Conclusions: LAD at an energy of 2.0 J/cm2 (570 mJ) is as effective, with similar adverse events, as an energy of 3.5 J/cm2 (1000 mJ) in facilitating topical anesthesia.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Anesthetics, Local / administration & dosage*
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Delivery Systems / instrumentation
  • Drug Delivery Systems / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Lasers* / adverse effects
  • Lidocaine / administration & dosage*
  • Male
  • Middle Aged
  • Ointments
  • Pain / etiology
  • Pain / prevention & control*
  • Pain Measurement
  • Phlebotomy / adverse effects*
  • Reference Values
  • Time Factors

Substances

  • Anesthetics, Local
  • Ointments
  • Lidocaine